Your browser doesn't support javascript.
loading
Potential approaches for the pricing of cancer medicines across Europe to enhance the sustainability of healthcare systems and the implications.
Godman, Brian; Hill, Andrew; Simoens, Steven; Selke, Gisbert; Selke Krulichová, Iva; Zampirolli Dias, Carolina; Martin, Antony P; Oortwijn, Wija; Timoney, Angela; Gustafsson, Lars L; Voncina, Luka; Kwon, Hye-Young; Gulbinovic, Jolanta; Gotham, Dzintars; Wale, Janet; Cristina Da Silva, Wânia; Bochenek, Tomasz; Allocati, Eleonora; Kurdi, Amanj; Ogunleye, Olayinka O; Meyer, Johanna C; Hoxha, Iris; Malaj, Admir; Hierländer, Christian; Sauermann, Robert; Hamelinck, Wouter; Petrova, Guenka; Laius, Ott; Langner, Irene; Yfantopoulos, John; Joppi, Roberta; Jakupi, Arianit; Greiciute-Kuprijanov, Ieva; Vella Bonanno, Patricia; Piepenbrink, Jf Hans; de Valk, Vincent; Wladysiuk, Magdalene; Markovic-Pekovic, Vanda; Mardare, Ileana; Fürst, Jurij; Tomek, Dominik; Obach Cortadellas, Mercè; Zara, Corinne; Pontes, Caridad; McTaggart, Stuart; Laba, Tracey-Lea; Melien, Øyvind; Wong-Rieger, Durhane; Bae, SeungJin; Hill, Ruaraidh.
Afiliação
  • Godman B; Division of Clinical Pharmacology, Karolinska Institute, Karolinska University Hospital Huddinge, Stockholm, Sweden.
  • Hill A; Division of Pharmacoepidemiology, Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, UK.
  • Simoens S; Division of Public Health Pharmacy and Management, School of Pharmacy, Sefako Makgatho Health Sciences University, Pretoria, South Africa.
  • Selke G; School of Pharmaceutical Sciences, Universiti Sains Malaysia, Penang, Malaysia.
  • Selke Krulichová I; Institute of Translational Medicine, University of Liverpool, UK.
  • Zampirolli Dias C; Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Belgium.
  • Martin AP; Wissenschaftliches Institut Der AOK (WIdO), Berlin, Germany.
  • Oortwijn W; Department of Medical Biophysics, Faculty of Medicine in Hradec Králové, Charles University, Hradec, Králové, Czech Republic.
  • Timoney A; Faculty of Pharmacy, Postgraduate Program in Medicines and Pharmaceutical Services, Federal University of Minas Gerais (UFMG), Belo Horizonte, Minas Gerais, Brazil.
  • Gustafsson LL; SUS Collaborating Centre for Technology Assessment and Excellence in Health (CCATES), Belo Horizonte, Minas Gerais, Brazil.
  • Voncina L; Faculty of Health and Life Sciences, Liverpool, UK.
  • Kwon HY; QC Medica, Sim Balk Lane, York UK.
  • Gulbinovic J; Department for Health Evidence, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Gotham D; Division of Pharmacoepidemiology, Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, UK.
  • Wale J; NHS Lothian, Edinburgh, UK.
  • Cristina Da Silva W; Division of Clinical Pharmacology, Karolinska Institute, Karolinska University Hospital Huddinge, Stockholm, Sweden.
  • Bochenek T; Faculty of Health Studies, Rijeka, Croatia.
  • Allocati E; Division of Pharmacoepidemiology, Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, UK.
  • Kurdi A; Division of Biology & Public Health, Mokwon University, Daejeon, Korea.
  • Ogunleye OO; Department of Pathology, Forensic Medicine and Pharmacology, Institute of Biomedical Sciences, Faculty of Medicine, Vilnius University, Vilnius, Lithuania.
  • Meyer JC; Independent Researcher, Boston, MA, United States.
  • Hoxha I; Independent Consumer Advocate, Brunswick, Victoria, Australia.
  • Malaj A; Faculty of Pharmacy, Postgraduate Program in Medicines and Pharmaceutical Services, Federal University of Minas Gerais (UFMG), Belo Horizonte, Minas Gerais, Brazil.
  • Hierländer C; Data and Knowledge Integration Center for Health(CIDACS), Fundação Oswaldo Cruz (FIOCRUZ)/ Salvador, Bahia, Brazil.
  • Sauermann R; Department of Nutrition and Drug Research, Faculty of Health Sciences, Jagiellonian University Medical College, Krakow, Poland.
  • Hamelinck W; Istituto Di Ricerche Farmacologiche 'Mario Negri' IRCCS, Milan, Italy.
  • Petrova G; Division of Pharmacoepidemiology, Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, UK.
  • Laius O; Division of Public Health Pharmacy and Management, School of Pharmacy, Sefako Makgatho Health Sciences University, Pretoria, South Africa.
  • Langner I; Department of Pharmacology, College of Pharmacy, Hawler Medical University, Erbil, Iraq.
  • Yfantopoulos J; Department of Pharmacology, Therapeutics and Toxicology, Lagos State University College of Medicine, Ikeja, Lagos, Nigeria.
  • Joppi R; Department of Medicine, Lagos State University Teaching Hospital, Ikeja, Lagos, Nigeria.
  • Jakupi A; Division of Public Health Pharmacy and Management, School of Pharmacy, Sefako Makgatho Health Sciences University, Pretoria, South Africa.
  • Greiciute-Kuprijanov I; Department of Pharmacy, Faculty of Medicine, University of Medicine, Tirana, Albania.
  • Vella Bonanno P; University of Medicine, Tirana, Albania.
  • Piepenbrink JH; Department of Pharmaceutical Affairs, Federation of Social Insurances, Vienna, Austria.
  • de Valk V; Department of Pharmaceutical Affairs, Federation of Social Insurances, Vienna, Austria.
  • Wladysiuk M; Statistics Department, Bruxelles, Belgium.
  • Markovic-Pekovic V; Faculty of Pharmacy, Department of Social Pharmacy and Pharmacoeconomics, Medical University of Sofia, Sofia, Bulgaria.
  • Mardare I; State Agency of Medicines, Tartu, Estonia.
  • Fürst J; Wissenschaftliches Institut Der AOK (WIdO), Berlin, Germany.
  • Tomek D; School of National and Kapodistrian University of Athens Athens Greece.
  • Obach Cortadellas M; Pharmaceutical Drug Department, Azienda Sanitaria Locale of Verona, Verona, Italy.
  • Zara C; Faculty of Pharmacy, UBT - Higher Education Institution, Prishtina, Kosovo.
  • Pontes C; Department of Pharmacy, Ministry of Health of the Republic of Lithuania, Vilnius, Lithuania.
  • McTaggart S; Division of Pharmacoepidemiology, Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, UK.
  • Laba TL; National Health Care Institute (ZIN), XH, Diemen, Netherlands.
  • Melien Ø; National Health Care Institute (ZIN), XH, Diemen, Netherlands.
  • Wong-Rieger D; HTA Consulting, Cracow, Poland.
  • Bae S; Faculty of Medicine, Department of Social Pharmacy, University of Banja Luka, Banja Luka, Republic of Srpska, Bosnia and Herzegovina.
  • Hill R; Faculty of Medicine, Public Health and Management Department, "Carol Davila" University of Medicine and Pharmacy Bucharest, Bucharest, Romania.
Expert Rev Pharmacoecon Outcomes Res ; 21(4): 527-540, 2021 Aug.
Article em En | MEDLINE | ID: mdl-33535841
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Custos de Medicamentos / Atenção à Saúde / Neoplasias / Antineoplásicos Tipo de estudo: Health_economic_evaluation / Prognostic_studies Limite: Humans País/Região como assunto: Europa Idioma: En Revista: Expert Rev Pharmacoecon Outcomes Res Assunto da revista: FARMACOLOGIA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Suécia
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Custos de Medicamentos / Atenção à Saúde / Neoplasias / Antineoplásicos Tipo de estudo: Health_economic_evaluation / Prognostic_studies Limite: Humans País/Região como assunto: Europa Idioma: En Revista: Expert Rev Pharmacoecon Outcomes Res Assunto da revista: FARMACOLOGIA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Suécia